Deciphera Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary

Deciphera Pharmaceuticals

09/08/2023 13:00

* Deciphera Pharmaceuticals Inc  DCPH.OQ  reported a
quarterly
adjusted loss of 57 cents​​ per share for the quarter ended in
June. The mean expectation of ten analysts for the quarter was
for a loss of 62 cents per share.
    * Revenue rose 17.9% to $38.30 million from a year ago;
analysts
expected $35.88 million. 
    * Deciphera Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 5 cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Deciphera Pharmaceuticals Inc shares had fallen by 8.1%
this
quarter and lost 21.0% so far this year.
    * The company reported a quarterly loss of $4.21 million.
    * Wall Street's median 12-month price target for Deciphera
Pharmaceuticals Inc is $22.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 9 at 12:00 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.62          -0.57          Beat
 Mar. 31 2023      -0.59          -0.60          Missed
 Dec. 31 2022      -0.56          -0.60          Missed
 Sep. 30 2022      -0.58          -0.55          Beat